AAAAAA
Results: 1-25/35
Authors:
Charpentier, G
Vaur, L
Halimi, S
Fleury, F
Derobert, E
Grimaldi, A
Oriol, V
Etienne, S
Altman, JJ
Citation: G. Charpentier et al., Predictors of response to glimepiride in patients with type 2 diabetes mellitus, DIABETE MET, 27(5), 2001, pp. 563-571
Authors:
Halimi, S
Citation: S. Halimi, Type 2 diabetes mellitus: Which place for thiazolidinediones in the therapeutic strategy?, DIABETE MET, 27(2), 2001, pp. 287-293
Authors:
Turnin, MC
Bourgeois, O
Cathelineau, G
Leguerrier, AM
Halimi, S
Sandre-Banon, D
Coliche, V
Breux, M
Verlet, E
Labrousse, F
Bensoussan, D
Grenier, JL
Poncet, MF
Tordjmann, F
Brun, JM
Blickle, JF
Mattei, C
Bolzonella, C
Buisson, JC
Fabre, D
Tauber, JP
Hanaire-Broutin, H
Citation: Mc. Turnin et al., Multicenter randomized evaluation of a nutritional education software in obese patients, DIABETE MET, 27(2), 2001, pp. 139-147
Authors:
Hardy, G
Stanke-Labesque, F
Peoc'h, M
Hakim, A
Devillier, P
Caron, F
Morel, S
Faure, P
Halimi, S
Bessard, G
Citation: G. Hardy et al., Cysteinyl leukotrienes modulate angiotensin II constrictor effects on aortas from streptozotocin-induced diabetic rats, ART THROM V, 21(11), 2001, pp. 1751-1758
Authors:
Gomez, JL
Thony, F
Maynard, C
Zaoui, P
Janbon, B
Coulomb, M
Halimi, S
Cordonnier, D
Citation: Jl. Gomez et al., Magnetic resonance angiographic patterns of renal artery stenosis in patients with chronic uraemia: differences between type 2 diabetic and non-diabetic patients, NEPH DIAL T, 16(4), 2001, pp. 871-872
Authors:
Ramon, O
Wong, HK
Joyeux, M
Riondel, J
Halimi, S
Ravanat, JL
Favier, A
Cadet, J
Faure, P
Citation: O. Ramon et al., 2 '-deoxyguanosine oxidation is associated with decrease in the DNA-binding activity of the transcription factor Sp1 in liver and kidney from diabetic and insulin-resistant rats, FREE RAD B, 30(1), 2001, pp. 107-118
Authors:
Charpentier, G
Fleury, F
Kabir, M
Vaur, L
Halimi, S
Citation: G. Charpentier et al., Improved glycaemic control by addition of glimepiride to metformin monotherapy in Type 2 diabetic patients, DIABET MED, 18(10), 2001, pp. 828-834
Authors:
Benhamou, PY
Mouret, S
Quesada, JL
Boizel, R
Baguet, JP
Halimi, S
Mallion, JM
Citation: Py. Benhamou et al., Variations of ambulatory blood pressure with position in patients with type 1 diabetes - Influence of disease duration and microangiopathy in a pilotstudy, DIABET CARE, 24(9), 2001, pp. 1624-1628
Authors:
Cordonnier, DJ
Zaoui, P
Halimi, S
Citation: Dj. Cordonnier et al., Role of ACE inhibitors in patients with diabetes mellitus, DRUGS, 61(13), 2001, pp. 1883-1892
Authors:
Zaoui, P
Cantin, JF
Alimardani-Bessette, M
Monier, F
Halimi, S
Morel, F
Cordonnier, D
Citation: P. Zaoui et al., Role of metalloproteases and inhibitors in the occurrence and progression of diabetic renal lesions, DIABETE MET, 26, 2000, pp. 25-29
Authors:
Grimaldi, A
Halimi, S
Citation: A. Grimaldi et S. Halimi, A need for therapeutic research in diabetic foot lesions healing, DIABETE MET, 26(2), 2000, pp. 92-92
Authors:
Carpentier, B
Pradines, S
Benhamou, PY
Halimi, S
Citation: B. Carpentier et al., A comparative study of the costs of diabetic foot in the developped countries., DIABETE MET, 26(1), 2000, pp. 75-80
Authors:
Bourquelot, P
Buisson, C
Chanard, J
Cordonnier, D
Drueke, T
Dupuy, CA
Gin, H
Halimi, S
Hannedouche, T
Jacobs, C
Kourilsky, O
Lalau, JD
Pirson, Y
Ryckelynck, JP
Vialettes, B
Citation: P. Bourquelot et al., Report of the expert committee. ALFEDIAM and SFN. Management of end stage renal disease in diabetic patients. Short text, DIABETE MET, 26(1), 2000, pp. 81-87
Authors:
Cordonnier, DJ
Cantin, JF
Pinel, N
Zaoui, P
Castro, PP
Vanhille, P
Verrier-Mine, O
Halimi, S
Citation: Dj. Cordonnier et al., Diversity of kidney disease in patients with type 2 diabetes mellitus, PRESSE MED, 29(35), 2000, pp. 1957-1961
Authors:
Halimi, S
Citation: S. Halimi, Dyslipidemias in diabetes and insulin resistance, NEPHROLOGIE, 21(7), 2000, pp. 345-346
Authors:
Vanzetto, G
Fouque, D
Moulin, B
Halimi, S
Kessler, M
Bayle, F
Boizel, R
Skurdens, T
Pradines, S",Hadjian,Rieckelink,"Mourad, G
Foret, M
Ruiz, J
Chanard, J
Hannedouche, T
Citation: G. Vanzetto et al., Round table on therapeutic management, NEPHROLOGIE, 21(7), 2000, pp. 383-392
Authors:
Halimi, S
Rostoker, G
Altman, JJ
Attali, C
Beaune, J
Belorgey-Bismut, C
Bouldouyre-Magnier, AM
Cordonnier, D
Denis, C
Duranteau, L
Grimaldi, A
Guillausseau, PJ
Koenig, F
Lagrue, G
Monnier, L
Orgiazzi, J
Raucoules-Aime, M
Saltiel, H
Simon, D
Varroud-Vial, M
Citation: S. Halimi et al., Guidelines for medical treatment of type 2 diabetes: condensed text, J FR OPHTAL, 23(3), 2000, pp. 302-306
Authors:
Halimi, S
Le Berre, MA
Grange, V
Citation: S. Halimi et al., Efficacy and safety of acarbose add-on therapy in the treatment of overweight patients with Type 2 diabetes inadequately controlled with metformin: adouble-blind, placebo-controlled study, DIABET RE C, 50(1), 2000, pp. 49-56
Authors:
Boizel, R
Benhamou, PY
Lardy, B
Laporte, F
Foulon, T
Halimi, S
Citation: R. Boizel et al., Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels, DIABET CARE, 23(11), 2000, pp. 1679-1685
Authors:
Machecourt, J
Neuder, Y
Halimi, S
Ormezzano, O
Fagret, D
Vanzetto, G
Citation: J. Machecourt et al., Which coronary investigations in asymptomatic diabetics, ARCH MAL C, 93, 2000, pp. 33-38
Authors:
Halimi, S
Rostoker, G
Altman, JJ
Attali, C
Beaune, J
Belorgey-Bismut, C
Bouldouyre-Magnier, AM
Cordonnier, D
Denis, C
Duranteau, L
Grimaldi, A
Guillausseau, PJ
Koenig, F
Lagrue, G
Monnier, L
Orgiazzi, F
Raucoules-Aime, M
Saltiel, H
Simon, D
Varroud-Vial, M
Citation: S. Halimi et al., Guideliness for drug treatment of type 2 diabetes mellitus, ANN ENDOCR, 61(2), 2000, pp. 168-173
Authors:
Lopez, JF
Halimi, S
Perillat, Y
Citation: Jf. Lopez et al., Pellagra-like erythema following vertical banded gastroplasty for morbid obesity, ANN CHIR, 125(3), 2000, pp. 297-298
Authors:
Halimi, S
Zmirou, D
Benhamou, PY
Balducci, F
Zaoui, P
Maghlaoua, M
Cordonnier, D
Citation: S. Halimi et al., Huge progression of diabetes prevalence and incidence among dialysed patients in mainland France and overseas french territories. A second national survey six years apart. (UREMIDIAB 2 study), DIABETE MET, 25(6), 1999, pp. 507-512
Authors:
Halimi, S
Rostoker, G
Altman, JJ
Attali, C
Beaune, J
Belorgey-Bismut, C
Bouldouyre-Magnier, AM
Cordonnier, D
Denis, C
Duranteau, L
Grimaldi, A
Guillausseau, PJ
Koenig, F
Lagrue, G
Monnier, L
Orgiazzi, J
Raucoules-Aime, M
Saltiel, H
Simon, D
Varroud-Vial, M
Citation: S. Halimi et al., The treatment of type 2 diabetes. Report of the expert commitee of the AFSSAPS, DIABETE MET, 25(6), 1999, pp. 533-550
Authors:
Bourquelot, P
Buisson, C
Chanard, J
Cordonnier, D
Drueke, T
Dupuy, CA
Gin, H
Halimi, S
Hannedouche, T
Jacobs, C
Kourilsky, O
Lalau, JD
Pirson, Y
Vialettes, B
Citation: P. Bourquelot et al., Management of Uremic Diabetes - Guidelines for Clinical Practice - Joint report of ALFEDIAM and the Societe de Nephrologie, DIABETE MET, 25, 1999, pp. 7-72